Multiple myeloma (first line) - bortezomib and thalidomide: response to scrutiny letter
|
Multiple myeloma (first line) - bortezomib and thalidomide: response to scrutiny letter
15 November 2010 (187.11 Kb 54 sec) |
This page was last updated: 16 December 2010